Status:
COMPLETED
Incidence of Paroxysmal Atrial Fibrillation (AF) in Patients With Acute Ischemic Stroke or Transient Ischemic Attacks (TIAs) by 48 Hours Holter Monitoring
Lead Sponsor:
Helwan University
Conditions:
Transient Ischemic Attack
Eligibility:
All Genders
20+ years
Brief Summary
200 patients presenting with symptoms of acute ischemic stroke or transient ischemic attack were included. All patients free of AF on presentation underwent 48 hours Holter monitoring within one week.
Eligibility Criteria
Inclusion
- patient with acute ischemic stroke or TIAs (within one week of onset)
Exclusion
- history of persistent AF
- initial ECG is AF
- primary hemorrhagic stroke
- acute large vessel dissection
- inability or refusal of consent
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04679987
Start Date
March 1 2019
End Date
December 1 2020
Last Update
December 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohamed Badr
Cairo, Egypt, 11461